There are currently 34 ongoing clinical trials involving Dengue Fever
Of the 34 trials,10 trials are in Phase I
Furthermore, 7 trials are in Phase II
The global pharmaceutical industry is steadily developing new drugs for Dengue Fever, an infectious disease. The largest number of ongoing clinical trials of Dengue Fever are in the Asia-Pacific region. North America and South and Central America are among some of the other prominent regions involved in Dengue Fever-related drug trials.
Dengue Fever related clinical trials sponsors Sanofi Pasteur SA, Dr. Mehta's Hospital Pvt Ltd, University of the Philippines System, Johnson & Johnson, and Takeda Pharmaceutical Co Ltd are a few notable clinical trials sponsors involving Dengue Fever. A clinical trial sponsor can be a Company, Government, Individual, or Institution.
Marketed Drugs involving Dengue Fever
Dengue vaccine (ChimeriVax Tetravalent Dengue Vaccine/Dengvaxia) is the sole key marketed drug involving Dengue Fever.
Dengue vaccine (ChimeriVax Tetravalent Dengue Vaccine/Dengvaxia) is a live, attenuated vaccine that acts as an immunizing agent. Chimeric tetravalent dengue vaccine consists of live attenuated yellow fever virus 17D strain with structural genes replaced with the corresponding dengue structural genes. The therapeutic candidate is capable of inducing a humoral immune response and cellular immune response leading to the production of B and T-lymphocytes It is formulated as a powder for suspension for the subcutaneous route of administration. It is indicated for the prevention of disease caused by all four dengue types in individuals from 9-45 years of age living in endemic areas. CYD (ChimeriVax-DEN) is developed by using ChimeriVax technology. ChimeriVax is a family of live, genetically engineered viruses. Dengue vaccine was first approved in 2015 and is marketed globally including the US, the UK, France, and Germany by Sanofi Pasteur Inc.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward